Encompass Health Corporation $EHC Shares Sold by Wealth Enhancement Advisory Services LLC

Key Points

• Wealth Enhancement Advisory Services LLC has reduced its stake in Encompass Health Corporation by 11.6%, leaving it with 16,551 shares worth approximately $1.97 million.
• Encompass Health reported $1.40 earnings per share for its last quarter, exceeding analysts' expectations of $1.20, and set its FY 2025 guidance between 5.120-5.340 EPS.
• The company has declared a quarterly dividend of $0.19, up from the previous $0.17, with a payout ratio of 13.31% and an annualized yield of 0.6%.

Wealth Enhancement Advisory Services LLC reduced its position in Encompass Health Corporation (NYSE:EHC - Free Report) by 11.6% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 16,551 shares of the company's stock after selling 2,164 shares during the period. Wealth Enhancement Advisory Services LLC's holdings in Encompass Health were worth $1,970,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently bought and sold shares of EHC. WPG Advisers LLC acquired a new position in Encompass Health during the 1st quarter worth approximately $27,000. Mitsubishi UFJ Asset Management Co. Ltd. lifted its position in Encompass Health by 749.0% during the 1st quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 416 shares of the company's stock worth $42,000 after acquiring an additional 367 shares in the last quarter. Arlington Trust Co LLC lifted its position in Encompass Health by 22.9% during the 1st quarter. Arlington Trust Co LLC now owns 671 shares of the company's stock worth $68,000 after acquiring an additional 125 shares in the last quarter. Caitong International Asset Management Co. Ltd lifted its position in Encompass Health by 19.0% during the 1st quarter. Caitong International Asset Management Co. Ltd now owns 720 shares of the company's stock worth $73,000 after acquiring an additional 115 shares in the last quarter. Finally, SVB Wealth LLC acquired a new position in Encompass Health during the 1st quarter worth approximately $84,000. 97.25% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Several equities analysts recently commented on EHC shares. Bank of America boosted their price target on Encompass Health from $145.00 to $160.00 and gave the stock a "buy" rating in a research report on Wednesday, September 10th. Truist Financial boosted their price target on Encompass Health from $135.00 to $140.00 and gave the stock a "buy" rating in a research report on Thursday, August 14th. Wall Street Zen downgraded Encompass Health from a "strong-buy" rating to a "buy" rating in a report on Friday, June 6th. UBS Group lifted their price objective on Encompass Health from $130.00 to $140.00 and gave the stock a "buy" rating in a report on Wednesday, August 6th. Finally, KeyCorp lifted their price objective on Encompass Health from $135.00 to $140.00 and gave the stock an "overweight" rating in a report on Tuesday, September 16th. One investment analyst has rated the stock with a Strong Buy rating and seven have given a Buy rating to the company. According to data from MarketBeat.com, the stock currently has an average rating of "Buy" and an average price target of $138.43.

Encompass Health Price Performance

Shares of NYSE EHC opened at $126.78 on Monday. Encompass Health Corporation has a twelve month low of $87.85 and a twelve month high of $127.86. The company has a current ratio of 1.06, a quick ratio of 1.06 and a debt-to-equity ratio of 0.76. The company has a market capitalization of $12.77 billion, a price-to-earnings ratio of 24.81, a price-to-earnings-growth ratio of 2.22 and a beta of 0.92. The business has a 50 day simple moving average of $119.60 and a 200-day simple moving average of $114.84.

Encompass Health (NYSE:EHC - Get Free Report) last issued its quarterly earnings results on Monday, August 4th. The company reported $1.40 earnings per share for the quarter, beating analysts' consensus estimates of $1.20 by $0.20. Encompass Health had a return on equity of 17.83% and a net margin of 9.22%.The business had revenue of $1.46 billion during the quarter, compared to the consensus estimate of $1.43 billion. During the same period in the previous year, the business earned $1.11 EPS. The business's quarterly revenue was up 12.0% on a year-over-year basis. Encompass Health has set its FY 2025 guidance at 5.120-5.340 EPS. As a group, equities research analysts expect that Encompass Health Corporation will post 4.8 earnings per share for the current year.

Encompass Health Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Wednesday, October 15th. Stockholders of record on Wednesday, October 1st will be issued a $0.19 dividend. This is a positive change from Encompass Health's previous quarterly dividend of $0.17. The ex-dividend date is Wednesday, October 1st. This represents a $0.76 dividend on an annualized basis and a dividend yield of 0.6%. Encompass Health's dividend payout ratio (DPR) is presently 13.31%.

Insider Buying and Selling

In related news, EVP Patrick William Tuer sold 1,020 shares of the company's stock in a transaction on Wednesday, August 27th. The stock was sold at an average price of $123.59, for a total transaction of $126,061.80. Following the completion of the transaction, the executive vice president directly owned 18,846 shares in the company, valued at $2,329,177.14. This represents a 5.13% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. 2.10% of the stock is currently owned by insiders.

Encompass Health Company Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.